9 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... Evaluation and Management ... #Hematology #SickleCell ... Manifestations #Workup ... #Algorithm #Ddxof
Algorithm for the Evaluation of Thrombocytopenia

#Diagnosis #Hematology #Thrombocytopenia #Workup #Algorithm #Ddxof
Algorithm for the ... #Diagnosis #Hematology ... Thrombocytopenia #Workup ... #Algorithm #Ddxof
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... Embolism #Treatment #Algorithm ... #management #hematology
Petechiae/Purpura - Diagnostic Algorithm. Pathophysiology: 1) Represent the passage of erythrocytes from the intravascular to extravascular
Purpura - Diagnostic Algorithm ... commonly renal and pulmonary ... #Diagnosis #Dermatology ... Purpura #Palpable #Algorithm ... #Differential #Ddxof
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... vein thrombosis; PE ... = pulmonary embolism ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... incidental DVT or PE ... single subsegmental PE ... Anticoagulation #Management ... #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Imaging: CXR- pulmonary ... Infection (sepsis), PE ... APML #diagnosis #management ... #hematology #oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... proximal DVT or PE ... Thromboembolism #Treatment #Algorithm ... #management #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/PE ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology